Guggenheim Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.8M Buy
316,466
+14,569
+5% +$1.18M 0.16% 121
2026
Q1
$26.2M Sell
301,897
-33,005
-10% -$3.16M 0.2% 101
2025
Q4
$32.2M Sell
334,902
-26,995
-7% -$2.62M 0.23% 87
2025
Q3
$34.5M Sell
361,897
-38,027
-10% -$3.5M 0.25% 80
2025
Q2
$34.9M Sell
399,924
-28,392
-7% -$2.41M 0.28% 74
2025
Q1
$38.5M Sell
428,316
-56,675
-12% -$5.07M 0.35% 59
2024
Q4
$38.7M Sell
484,991
-81,459
-14% -$7.05M 0.31% 64
2024
Q3
$51M Buy
566,450
+8,025
+1% +$675K 0.36% 48
2024
Q2
$44M Buy
558,425
+26,403
+5% +$2.16M 0.31% 59
2024
Q1
$46.4M Buy
532,022
+39,960
+8% +$3.41M 0.33% 53
2023
Q4
$40.5M Buy
492,062
+39,137
+9% +$2.98M 0.31% 56
2023
Q3
$35.5M Buy
452,925
+28,884
+7% +$2.42M 0.31% 62
2023
Q2
$37.4M Buy
424,041
+23,628
+6% +$2.03M 0.29% 61
2023
Q1
$32.3M Buy
400,413
+84,680
+27% +$6.9M 0.27% 69
2022
Q4
$24.5M Buy
315,733
+73,921
+31% +$5.99M 0.22% 94
2022
Q3
$19.5M Buy
241,812
+35,385
+17% +$3.18M 0.18% 125
2022
Q2
$18.5M Sell
206,427
-17,271
-8% -$1.75M 0.15% 159
2022
Q1
$24.8M Buy
223,698
+20,503
+10% +$2.17M 0.15% 148
2021
Q4
$21M Buy
203,195
+18,640
+10% +$2.16M 0.11% 196
2021
Q3
$23.1M Buy
184,555
+2,710
+1% +$351K 0.14% 147
2021
Q2
$22.6M Sell
181,845
-30,554
-14% -$3.84M 0.13% 160
2021
Q1
$25.1M Sell
212,399
-17,831
-8% -$2.09M 0.16% 121
2020
Q4
$27M Sell
230,230
-798
-0.3% -$87.8K 0.17% 98
2020
Q3
$24M Sell
231,028
-31,362
-12% -$3.15M 0.17% 100
2020
Q2
$24.1M Buy
262,390
+1,263
+0.5% +$121K 0.19% 100
2020
Q1
$23.5M Sell
261,127
-52,254
-17% -$5.56M 0.24% 82
2019
Q4
$35.6M Buy
313,381
+40,100
+15% +$4.4M 0.27% 59
2019
Q3
$29.7M Sell
273,281
-14,638
-5% -$1.53M 0.24% 79
2019
Q2
$28M Sell
287,919
-17,111
-6% -$1.56M 0.23% 76
2019
Q1
$27.8M Buy
305,030
+26,931
+10% +$2.41M 0.23% 73
2018
Q4
$25.3M Buy
278,099
+12,212
+5% +$1.14M 0.21% 71
2018
Q3
$26.2M Sell
265,887
-24,385
-8% -$2.25M 0.17% 97
2018
Q2
$24.9M Sell
290,272
-572,744
-66% -$47.8M 0.17% 97
2018
Q1
$69.2M Sell
863,016
-31,936
-4% -$2.63M 0.17% 139
2017
Q4
$72.3M Buy
894,952
+66,060
+8% +$5.29M 0.17% 146
2017
Q3
$64.5M Buy
828,892
+36,638
+5% +$3.04M 0.15% 149
2017
Q2
$70.3M Buy
792,254
+10,015
+1% +$844K 0.19% 110
2017
Q1
$63M Sell
782,239
-66,421
-8% -$5.19M 0.17% 144
2016
Q4
$60.5M Buy
848,660
+183,586
+28% +$14.4M 0.17% 123
2016
Q3
$57.5M Buy
665,074
+23,247
+4% +$2.03M 0.18% 111
2016
Q2
$55.7M Sell
641,827
-33,513
-5% -$2.71M 0.17% 130
2016
Q1
$50.7M Sell
675,340
-116,237
-15% -$8.75M 0.16% 153
2015
Q4
$60.9M Sell
791,577
-85,405
-10% -$6.43M 0.18% 115
2015
Q3
$58.7M Sell
876,982
-87,588
-9% -$6.45M 0.18% 99
2015
Q2
$71.5M Buy
964,570
+119,073
+14% +$9.1M 0.18% 95
2015
Q1
$65.9M Buy
845,497
+96,868
+13% +$7.34M 0.16% 136
2014
Q4
$54M Sell
748,629
-41,782
-5% -$2.9M 0.14% 184
2014
Q3
$49M Buy
790,411
+103,965
+15% +$6.61M 0.12% 212
2014
Q2
$43.8M Buy
686,446
+55,747
+9% +$3.39M 0.11% 251
2014
Q1
$38.8M Buy
630,699
+59,863
+10% +$3.49M 0.11% 247
2013
Q4
$32.8M Buy
570,836
+150,555
+36% +$8.54M 0.1% 287
2013
Q3
$22.4M Buy
420,281
+37,933
+10% +$2.04M 0.08% 370
2013
Q2
$19.7M Buy
+382,348
New +$18.9M 0.08% 347

Other funds holding MDT

Guggenheim Capital's MDT Position: Q2 2026 in Review

Guggenheim Capital increased its Medtronic (MDT) stake by 4.8% in Q2 2026, buying an estimated $1.18M and bringing the position to 316,466 shares worth $24.8M. The position accounts for 0.16% of the portfolio, ranked #121.

Guggenheim Capital first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $72.3M in Q4 2017. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Guggenheim Capital held 316,466 shares of Medtronic worth $24.8M as of Q2 2026.
  • Guggenheim Capital bought 14,569 Medtronic shares in Q2 2026, an estimated $1.18M.
  • Medtronic made up 0.16% of Guggenheim Capital's portfolio in Q2 2026, its #121 holding.
  • Guggenheim Capital first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Guggenheim Capital's Medtronic position peaked at $72.3M in Q4 2017.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.